Cell Connections by Tunneling Nanotubes: Effects of Mitochondrial Trafficking on Target Cell Metabolism, Homeostasis, and Response to Therapy

Stem Cells International - Tập 2017 - Trang 1-14 - 2017
Marie‐Luce Vignais1, Andrés Caicedo2,3, Jean‐Marc Brondello1, Christian Jørgensen4,1
1IRMB, INSERM, Montpellier University, Montpellier, France
2Escuela de Medicina, Colegio de Ciencias de la Salud COCSA, Universidad San Francisco de Quito USFQ, Quito, Ecuador
3Instituto de Microbiología, Colegio de Ciencias Biológicas y Ambientales, Universidad San Francisco de Quito USFQ, Quito, Ecuador
4Department of Therapeutic Immuno-Rheumatology, Lapeyronie University Hospital, Montpellier, France

Tóm tắt

Intercellular communications play a major role in tissue homeostasis and responses to external cues. Novel structures for this communication have recently been described. These tunneling nanotubes (TNTs) consist of thin-extended membrane protrusions that connect cells together. TNTs allow the cell-to-cell transfer of various cellular components, including proteins, RNAs, viruses, and organelles, such as mitochondria. Mesenchymal stem cells (MSCs) are both naturally present and recruited to many different tissues where their interaction with resident cells via secreted factors has been largely documented. Their immunosuppressive and repairing capacities constitute the basis for many current clinical trials. MSCs recruited to the tumor microenvironment also play an important role in tumor progression and resistance to therapy. MSCs are now the focus of intense scrutiny due to their capacity to form TNTs and transfer mitochondria to target cells, either in normal physiological or in pathological conditions, leading to changes in cell energy metabolism and functions, as described in this review.

Từ khóa


Tài liệu tham khảo

10.1126/science.1093133

10.4049/jimmunol.173.3.1511

10.4161/cib.27934

10.1111/boc.201500004

10.1038/ncb1990

10.1242/jcs.129239

10.1186/s40478-016-0386-4

10.1038/cdd.2014.211

10.1089/scd.2011.0691

10.1101/gad.259341.115

10.1016/j.febslet.2009.03.065

10.1371/journal.pone.0021283

10.1016/j.yexcr.2008.08.022

10.1371/journal.pone.0033195

10.18632/aging.100341

10.1161/01.RES.0000168650.23479.0c

10.1371/journal.pone.0048020

10.1016/j.cell.2011.01.015

10.1038/nature14602

10.1371/journal.pone.0020230

10.4049/jimmunol.180.9.5779

10.1073/pnas.0910074107

10.1016/j.immuni.2005.08.009

10.4049/jimmunol.1401832

10.1038/ncb1841

10.1242/jcs.126086

10.1038/cddis.2013.245

10.4049/jimmunol.177.12.8476

10.1016/j.yexcr.2010.06.009

10.1002/stem.632

10.1002/embj.201386030

10.1038/nm.2736

10.1002/stem.2372

10.1016/j.mvr.2014.01.008

10.1038/srep09073

10.1186/1479-5876-11-94

10.1016/j.trsl.2014.05.011

10.3389/fphys.2014.00400

10.1371/journal.pone.0033093

10.1016/j.yexcr.2014.01.014

10.1016/j.cellbi.2005.05.013

10.1371/journal.pone.0099196

10.1016/j.humimm.2012.11.026

10.1096/fj.14-268615

10.1038/nature16071

10.18632/oncotarget.14695

10.1182/blood-2015-03-634238

10.1182/blood-2015-07-655860

10.1038/cdd.2010.147

10.1038/srep11453

10.3791/55245

10.1038/cddis.2016.358

10.1152/ajpheart.00883.2012

10.1080/19336896.2015.1025189

10.1038/srep20762

10.4049/jimmunol.1500845

10.1038/ncb1682

10.4161/cib.2.3.8165

10.1016/j.bpj.2011.03.007

10.1242/jcs.114033

10.1038/srep39632

10.1016/j.stemcr.2016.08.009

10.1083/jcb.200601067

10.7150/ijbs.15633

10.1016/j.cell.2014.06.007

10.1038/cdd.2013.61

10.1002/jcb.24166

10.1126/science.284.5411.143

10.1126/science.276.5309.71

10.1080/14653240600855905

10.1016/j.stem.2012.05.015

10.1006/bbrc.1999.1620

10.1006/bbrc.2001.6013

10.1126/science.1373518

10.1097/00022744-200106000-00001

10.1126/science.1698311

10.1016/S1074-7613(00)80278-2

10.1038/35053086

10.1002/stem.1681

10.1177/2041731414551763

10.1089/scd.2011.0722

10.1007/s12015-012-9365-8

10.1186/scrt442

10.1089/scd.2013.0016

10.1002/jcp.25255

10.1371/journal.pone.0048648

10.1016/j.gdata.2015.11.009

10.1096/fj.13-244640

10.1186/1756-8722-7-14

10.1016/j.tmrv.2015.11.004

10.1016/j.jcyt.2015.10.011

10.1146/annurev-immunol-032712-095919

2008, Stem Cells Dayton Ohio, 26, 212, 10.1634/stemcells.2007-0554

10.1371/journal.pone.0014247

10.1186/scrt2

10.1038/mt.2011.211

10.1371/journal.pone.0133934

10.1038/cdd.2013.149

10.18632/oncotarget.13907

10.1016/j.bbcan.2016.11.001

10.1016/j.yexcr.2010.07.002

10.1038/nature06188

10.1038/ncomms2766

10.1016/j.ctrv.2012.03.005

10.1007/s13277-016-5187-7

10.1016/j.bbcan.2016.10.004

10.18632/oncotarget.4732

10.1016/j.ccr.2011.08.010

10.4161/cbt.11.3.14179

10.1016/j.bbcan.2016.12.004

10.1016/j.bbcan.2017.01.002

10.1073/pnas.0510511103

10.1111/j.1582-4934.2007.00205.x

10.1038/ncomms9472

10.1038/nature18928

10.1111/jcmm.12316

10.1038/srep26057

10.1111/j.1749-6632.2010.05621.x

10.1016/j.cmet.2016.04.007

10.1093/humrep/13.10.2857

10.1262/jrd.2011-013

10.1095/biolreprod.104.036129

10.1165/rcmb.2013-0529OC